Fokas, E; Prevo, R; Pollard, JR; Reaper, PM; Charlton, P; Cornelissen, B; Vallis, K; Hammond, EM; Olcina, MM; McKenna, WG; Muschel, RJ; Brunner, TB.
ATR targeting by the novel inhibitor VE-822 selectively sensitizes pancreatic cancer cells and tumors to radiation and chemoradiation
STRAHLENTHER ONKOL. 2013; 189: 41-41.
Web of Science